Seth Rubin is General Counsel of Sapience Therapeutics. He brings over 25 years of experience in legal matters, including serving as outside general counsel to many of his clients. Prior to joining Sapience Therapeutics, Mr. Rubin was a partner at Ruskin Moscou Faltischek, where his practice focused on corporate and securities law. He represented private and public companies in a wide range of matters including mergers and acquisitions, strategic joint ventures, corporate finance, public and private financings, licensing, technology, and clinical trial agreements. He was also responsible for ensuring SEC compliance for his public company clients. Mr. Rubin provided a broad range of advice to early stage, late stage, and growth companies, including structuring financing for acquisitions, working capital, expansion, and exit strategies.
Mr. Rubin received his Juris Doctor from the University of Pennsylvania Law School and his Bachelor of Arts, cum laude, from Hobart College. Mr. Rubin is admitted to practice law in the State of New York.